prevalite

Generic: cholestyramine

Labeler: upsher-smith laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prevalite
Generic Name cholestyramine
Labeler upsher-smith laboratories, llc
Dosage Form POWDER, FOR SUSPENSION
Routes
ORAL
Active Ingredients

cholestyramine 4 g/5.5g

Manufacturer
Upsher-Smith Laboratories, LLC

Identifiers & Regulatory

Product NDC 0245-0036
Product ID 0245-0036_44feb603-0970-9b63-e063-6294a90a7ce5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA073263
Marketing Start 1996-02-01
Marketing End 2027-10-31

Pharmacologic Class

Established (EPC)
bile acid sequestrant [epc]
Mechanism of Action
bile-acid binding activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 02450036
Hyphenated Format 0245-0036

Supplemental Identifiers

RxCUI
848951 1801279
UNII
4B33BGI082
NUI
N0000180292 N0000175365

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prevalite (source: ndc)
Generic Name cholestyramine (source: ndc)
Application Number ANDA073263 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 g/5.5g
source: ndc
Packaging
  • 231 g in 1 CAN (0245-0036-23)
  • 42 PACKET in 1 CARTON (0245-0036-42) / 5.5 g in 1 PACKET (0245-0036-89)
  • 60 PACKET in 1 CARTON (0245-0036-60) / 5.5 g in 1 PACKET (0245-0036-89)
source: ndc

Packages (3)

0245-0036-23 231 g in 1 CAN (0245-0036-23) 0245-0036-42 42 PACKET in 1 CARTON (0245-0036-42) / 5.5 g in 1 PACKET (0245-0036-89) 0245-0036-60 60 PACKET in 1 CARTON (0245-0036-60) / 5.5 g in 1 PACKET (0245-0036-89)

Ingredients (1)

cholestyramine (4 g/5.5g)

Linked Drug Pages (1)

Prevalite ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "44feb603-0970-9b63-e063-6294a90a7ce5", "openfda": {"nui": ["N0000180292", "N0000175365"], "unii": ["4B33BGI082"], "rxcui": ["848951", "1801279"], "spl_set_id": ["dd434ef8-8af3-434c-a0a0-9a0b18459ba0"], "pharm_class_epc": ["Bile Acid Sequestrant [EPC]"], "pharm_class_moa": ["Bile-acid Binding Activity [MoA]"], "manufacturer_name": ["Upsher-Smith Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "231 g in 1 CAN (0245-0036-23)", "package_ndc": "0245-0036-23", "marketing_end_date": "20271031", "marketing_start_date": "19960201"}, {"sample": false, "description": "42 PACKET in 1 CARTON (0245-0036-42)  / 5.5 g in 1 PACKET (0245-0036-89)", "package_ndc": "0245-0036-42", "marketing_end_date": "20271031", "marketing_start_date": "19960201"}, {"sample": false, "description": "60 PACKET in 1 CARTON (0245-0036-60)  / 5.5 g in 1 PACKET (0245-0036-89)", "package_ndc": "0245-0036-60", "marketing_end_date": "20270930", "marketing_start_date": "19960201"}], "brand_name": "Prevalite", "product_id": "0245-0036_44feb603-0970-9b63-e063-6294a90a7ce5", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Bile Acid Sequestrant [EPC]", "Bile-acid Binding Activity [MoA]"], "product_ndc": "0245-0036", "generic_name": "cholestyramine", "labeler_name": "Upsher-Smith Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Prevalite", "active_ingredients": [{"name": "CHOLESTYRAMINE", "strength": "4 g/5.5g"}], "application_number": "ANDA073263", "marketing_category": "ANDA", "marketing_end_date": "20271031", "marketing_start_date": "19960201"}